Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03317964 · ClinicalTrials.gov registry record
Genetic Basis of Pacing-induced Cardiomyopathy
A clinical trial, sponsored by The Guthrie Clinic.
- Completed
- Registry status
- 153
- Enrollment target
NCT03317964: Completed study, sponsored by The Guthrie Clinic.
NCT03317964 is a clinical trial that has completed, run by The Guthrie Clinic. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03317964 has completed, sponsored by The Guthrie Clinic.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to collect a saliva sample from patients with a pacemaker to study genes involved in cardiomyopathy, a condition where the heart muscle is abnormal.
Primary Outcome
Number of participants with genotype frequency based on genetic testing of saliva samples
Interventions
- OTHER Saliva sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2025-06-19 |
What the finished NCT03317964 record still lists
NCT03317964 is an observational study that tracks outcomes without assigning an intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Saliva sample is the first listed.
NCT03317964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03317964 about?
NCT03317964 is a clinical study titled "Genetic Basis of Pacing-induced Cardiomyopathy". The purpose of this study is to collect a saliva sample from patients with a pacemaker to study genes involved in cardiomyopathy, a condition where the heart muscle is abnormal.
What is the current status of trial NCT03317964?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2017-10-16. Estimated completion is 2025-06-19.
What interventions are being tested in trial NCT03317964?
The interventions under investigation include: Saliva sample (OTHER).
Who is sponsoring clinical trial NCT03317964?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI